Live Breaking News & Updates on Ionis Pharmaceuticals Inc

Stay updated with breaking news from Ionis pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Critical Contrast: Biogen (NASDAQ:BIIB) and Poseida Therapeutics (NASDAQ:PSTX)

Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […] ....

United States , United Kingdom , San Diego , Alkermes Pharma Ireland , Sangamo Therapeutics Inc , Biogen Inc , Samsung Bioepis Co Ltd , Ionis Pharmaceuticals Inc , Denali Therapeutics Inc , Poseida Therapeutics Inc , Sage Therapeutics Inc , Genentech Inc , Roche Ltd , Acorda Therapeutics Inc , Roche Inc , Eisai Co Ltd , Get Free Report , Poseida Therapeutics , Poseida Therapeutic , Given Poseida Therapeutic , Acorda Therapeutics , Alkermes Pharma Ireland Limited , Neurimmune Subone , Ionis Pharmaceuticals , Sangamo Therapeutics , Sage Therapeutics ,

Ionis Pharmaceuticals : Login Information

Virtual Annual Meeting of Stockholders

All stockholders of record at the close of business on April 8, 2024, are invited to participate in the virtual Annual Meeting webcast,. ....

Hayley Soffer , D Wade Walke , Ionis Pharmaceuticals Inc , Prnewswire Ionis Pharmaceuticals Inc , Ionis Pharmaceuticals Investor Contact , Ionis Pharmaceuticals Media Contact , Annual Meeting , Ionis Pharmaceuticals , Pharmaceuticals Investor Contact , Pharmaceuticals Media Contact ,

Shareholders Will Probably Not Have Any Issues With Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) CEO Compensation

Key Insights Ionis Pharmaceuticals' Annual General Meeting to take place on 6th of June Salary of US$960.9k is part of. ....

Has Ionis Pharmaceuticals Inc , Ionis Pharmaceuticals Inc , Ionis Pharmaceuticals , A Look At Ionis Pharmaceuticals Inc ,

Biogen: EU Approves Qalsody To Treat Rare, Genetic Form Of Amyotrophic Lateral Sclerosis

WESTON (dpa-AFX) - Biogen Inc. (BIIB) said that the European Commission has granted marketing authorization under exceptional circumstances and maintained orphan designation for Qalsody (tofersen) ....

United States , European Union , More Such Health News , Biogen Inc , Ionis Pharmaceuticals Inc , European Commission , Ionis Pharmaceuticals , Ihr Portfolio ,

Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema

Donidalorsen delivered significant and sustained reductions in HAE attacks, with high levels of disease control and improvement in quality of life measures with monthly or every two-month dosing;. ....

United States , San Diego , Kenneth Newman , D Wade Walke , Hayley Soffer , Marc Riedl , European Academy Of Allergy , Exchange Commission , Angioedema Center , European Medicines Agency , Division Of Allergy Immunology , Otsuka Pharmaceutical Co Ltd , Drug Administration , Prnewswire Ionis Pharmaceuticals Inc , University Of California , Ionis Pharmaceuticals , Ionis Pharmaceuticals Inc , European Academy , Clinical Immunology , Annual Congress , Brett Monia , Study Results , Open Label Extension , New Drug Application , Marketing Authorization Application , Hereditary Angioedema ,